Browse Category

Legal News News 15 December 2025 - 22 December 2025

Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson (NYSE: JNJ) heads into the U.S. market open on Monday, December 22, 2025, with investors balancing a familiar mix of defensive-healthcare appeal and headline-driven catalysts—from fresh talc litigation verdicts to FDA-related momentum in oncology and MedTech. Below
Coinbase Stock (COIN) After Hours on Dec. 19, 2025: Lawsuits, Stablecoin Deals and Bitcoin Moves to Watch Before the Next Market Open

Coinbase Stock (COIN) After Hours on Dec. 19, 2025: Lawsuits, Stablecoin Deals and Bitcoin Moves to Watch Before the Next Market Open

Coinbase Global, Inc. (NASDAQ: COIN) finished Friday, Dec. 19, 2025, higher and then traded modestly in after-hours action—capping a volatile week in which crypto prices, regulatory headlines, and Coinbase’s push beyond pure crypto trading all competed for investor attention. In
Prediction Markets Surge on Dec. 19, 2025: Robinhood’s NFL “Combos,” DraftKings’ New Predictions App, Coinbase Lawsuits, and Polymarket’s Latest Turbulence

Prediction Markets Surge on Dec. 19, 2025: Robinhood’s NFL “Combos,” DraftKings’ New Predictions App, Coinbase Lawsuits, and Polymarket’s Latest Turbulence

On Friday, December 19, 2025, the fast-growing world of prediction markets—often framed as “event trading” and sometimes criticized as a backdoor to sports betting—delivered a cluster of developments that show just how quickly the category is moving from crypto niche
Coinbase Stock (NASDAQ: COIN) News on Dec. 19, 2025: Prediction‑Market Lawsuits, “Everything Exchange” Expansion, and Wall Street Forecasts

Coinbase Stock (NASDAQ: COIN) News on Dec. 19, 2025: Prediction‑Market Lawsuits, “Everything Exchange” Expansion, and Wall Street Forecasts

December 19, 2025 Coinbase Global, Inc. (NASDAQ: COIN) is back in the spotlight on Friday as investors weigh a fresh wave of legal headlines against the company’s biggest strategic pivot in years: becoming an “everything exchange” that blends crypto, stocks,
Johnson & Johnson Stock (JNJ) After Hours Today (Dec. 18, 2025): FDA Approvals, Analyst Targets, and Talc Litigation in Focus Ahead of Friday’s Open

Johnson & Johnson Stock (JNJ) After Hours Today (Dec. 18, 2025): FDA Approvals, Analyst Targets, and Talc Litigation in Focus Ahead of Friday’s Open

Johnson & Johnson (NYSE: JNJ) finished Thursday’s regular session lower even as the broader market moved higher, then ticked modestly upward in after-hours trading—leaving investors with a familiar year-end setup: solid pipeline/MedTech progress on one side, and talc litigation headlines
Telix Pharmaceuticals (TLX) Stock Slides on Dec. 17, 2025: ProstACT Phase 3 Update, FDA Zircaix Overhang, Lawsuit Headlines, and Fresh Analyst Forecasts

Telix Pharmaceuticals (TLX) Stock Slides on Dec. 17, 2025: ProstACT Phase 3 Update, FDA Zircaix Overhang, Lawsuit Headlines, and Fresh Analyst Forecasts

Telix Pharmaceuticals Limited (ASX:TLX, Nasdaq:TLX) entered the spotlight again on December 17, 2025, as TLX stock extended its December sell-off amid a fast-moving mix of clinical-trial updates, regulatory overhang, and investor litigation headlines. Telix Pharmaceuticals On the ASX, Telix shares
Visa Stock After Hours (Dec. 15, 2025): V Holds Near $347 as Stablecoin Push Collides With Swipe-Fee Legal Fight — What to Watch Before Tuesday’s Open

Visa Stock After Hours (Dec. 15, 2025): V Holds Near $347 as Stablecoin Push Collides With Swipe-Fee Legal Fight — What to Watch Before Tuesday’s Open

Visa Inc. (NYSE: V) finished Monday’s session slightly lower, then traded essentially flat after the closing bell—ending a day where investors had to weigh two very different storylines: Visa’s fresh stablecoin initiative and a renewed legal overhang tied to U.S.
Go toTop